Joel A. Cummings
- Molecular Biology
- Physiology top 10%
- Cell Biology top 10%
- Neurology
- Pharmacology
- Co-authors
- Alan D. SnowGerardo M. CastilloCatherine NgoThomas N. WightWen YangMalcolm J. SheardownMartin E. JudgeJohn‐Bjarne Hansen
- Topics
- Alzheimer's disease research and treatments (10 papers)Proteoglycans and glycosaminoglycans research (5 papers)Glycosylation and Glycoproteins Research (4 papers)
- Cited by
- Cell BiologyPhysiologyNeurology
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Joel A. Cummings
14 papers receiving 526 citations
Peers
Comparison fields: 5 of 72
- Molecular Biology 300
- Physiology 266
- Cell Biology 194
- Neurology 60
- Pharmacology 58
Countries citing papers authored by Joel A. Cummings
This map shows the geographic impact of Joel A. Cummings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel A. Cummings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel A. Cummings more than expected).
Fields of papers citing papers by Joel A. Cummings
This network shows the impact of papers produced by Joel A. Cummings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel A. Cummings. The network helps show where Joel A. Cummings may publish in the future.
Co-authorship network of co-authors of Joel A. Cummings
This figure shows the co-authorship network connecting the top 25 collaborators of Joel A. Cummings. A scholar is included among the top collaborators of Joel A. Cummings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel A. Cummings. Joel A. Cummings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 54 | |
| 2 | 10 | |
| 3 | 55 | |
| 4 | 5 | |
| 5 | 15 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 115 | |
| 11 | 218 | |
| 12 | 31 | |
| 13 | 19 | |
| 14 | Identification of anthracenyl-dipeptide conjugates as novel topoisomerase I and II inhibitors and their evaluation as potential anticancer drugs. | 11 |
About Joel A. Cummings
Joel A. Cummings is a scholar working on Physiology, Pharmacology and Cell Biology, having authored 14 papers that have together received 538 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (10 papers), Proteoglycans and glycosaminoglycans research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Cell Biology (194 citations), Physiology (266 citations) and Neurology (60 citations). Joel A. Cummings has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Alan D. Snow, Gerardo M. Castillo, Catherine Ngo, Thomas N. Wight, Wen Yang, Malcolm J. Sheardown, Martin E. Judge, John‐Bjarne Hansen, Rudolph E. Tanzi and Judy Cam. Their work appears in journals such as Diabetes, Scientific Reports and Journal of Neurochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.